Our division is focused on breast, lung, ovarian and rare cancers.

We are working to understand normal organ development and the problems in this process that give rise to cancer, with a view to discovering new therapies.

We have also established an extensive bank of patient-derived cancer samples for preclinical studies. These enable us to explore new treatments, study how cancer cells respond to drugs, and understand why drug resistance occurs.

Health impact

Cancers: breast cancer, lung cancer, ovarian cancer, rare cancers

Division news

• Discovery paves way for improved ovarian cancer care 
• Genomic sequencing offers new hope for rare cancers
• Gene silencing critical for normal breast development 
• Cancer ‘signature’ first step toward blood test for patients
• How sleeping mammary stem cells are awakened in puberty

Division heads

Professor Geoff Lindeman

Professor Jane Visvader

Lab heads

Dr Yunshun Chen

Dr Naiyang Fu

Professor Clare Scott

Associate Professor Kate Sutherland

Division coordinator

Dr Julia Man